Genomic Health Inc

Visual Financials
Company Name: Genomic Health Inc
Ticker Symbol: GHDX
CIK Number: 0001131324
WWW Address: http://www.genomichealth.com
CEO: Kimberly J. Popovits
No. of Employees: 846
Common Issue Type: CS
Business Description:Genomic Health, Inc. develops and commercializes genomic-based clinical laboratory services that analyze the underlying biology of cancer allowing physicians and patients to make individualized treatment decisions.

 
Industry Information: HEALTH SERVICES - Medical Laboratories & Research [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 55.3 Unchanged 0.0 35.88 58.0  57.44 53.80 40
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 2,050.1 37.1 0.00 0.72 0.00 78.2 0.0 92.18 - 36.94
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close56.28$
PE Ratio - LTM78.2
Market Capitalisation2,050.1mil
Latest Shares Outstanding37.1mil
Earnings pS (EPS)0.72$
Dividend pS (DPS)0.00¢
Dividend Yield0.0%
Dividend Payout Ratio%
Revenue per Employee475,405$
Effective Tax Rate0.0%
Float26.7mil
Float as % of Shares Outstanding0.7%
Foreign Salesmil
Domestic Salesmil
Selling, General & Adm/tive (SG&A) as % of Revenue0.60%
Research & Devlopment (R&D) as % of Revenue0.20%
Gross Profit Margin83.7%
EBITDA Margin9.3%
Pre-Tax Profit Margin0.0%
Assets Turnover139.3%
Return on Assets (ROA)9.1%
Return on Equity (ROE)11.2%
Return on Capital Invested (ROCI)10.2%
Current Ratio4.6
Leverage Ratio (Assets/Equity)1.2
Interest Cover
Total Debt/Equity (Gearing Ratio)
LT Debt/Total Capital0.0%
Working Capital pS5.80$
Cash pS1.32$
Book-Value pS7.77$
Tangible Book-Value pS7.29$
Cash Flow pS1.73$
Free Cash Flow pS1.45$
KEY FIGURES (LTM): Price info
Price/Book Ratio6.98
Price/Tangible Book Ratio0.00
Price/Cash Flow31.3
Price/Free Cash Flow37.3
P/E as % of Industry Group818.0%
P/E as % of Sector Segment654.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of Payment-
Dividend Rate0.00
Current Dividend Yield0.0
5-Y Average Dividend Yield0.0
Payout Ratio0.0
5-Y Average Payout Ratio0.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week----0.3483,591884,822
4 Weeks67.9453.0365.12-13.6384,9957,699,901
13 Weeks87.0053.0383.66-32.7431,02827,585,803
26 Weeks87.0053.0372.84-22.7395,57048,655,145
52 Weeks92.1836.9438.4946.2375,55993,889,838
YTD87.0053.03--9.5389,76337,807,062
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
55.5756.7565.8970.6468.360.000.00
 
GROWTH RATES5-Year
Growh
R² of 5-Year Growth3-Year
Growth
Revenue0.090.30.11
Income0.0
Dividend0.0
Capital Spending0.55NA
R&D14.39NA12.54
Normalized Inc.0.00NA0.00
 
CHANGESYTD vs.
Last YTD
Curr Qtr vs.
Qtr 1-Yr ago
Annual vs.
Last Annual
Revenue %7.97.914.1
Earnings %-100.0-100.05.1
EPS %-100.0-100.00.0
EPS $-0.05-0.050.00
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio64.32
Current Ratio4.6
Quick Ratio (Acid Test)4.4
Liquidity Ratio (Cash)4.54
Receivables Turnover9.5
Average Collection Period38
Working Capital/Equity79.6
Working Capital pS5.83
Cash-Flow pS2.04
Free Cash-Flow pS1.77
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio2.32
Financial Leverage Ratio (Assets/Equity)0.0
Debt Ratio0.0
Total Debt/Equity (Gearing Ratio)0.00
LT Debt/Equity0.00
LT Debt/Capital Invested0.0
LT Debt/Total Liabilities0.0
Interest Cover0.0
Interest/Capital Invested0.00
 
VALUATION RATIOS
MULTIPLES
PQ Ratio0.00
Tobin's Q Ratio6.01
Current P/E Ratio - LTM78.20
Enterprise Value (EV)/EBITDA47.51
Enterprise Value (EV)/Free Cash Flow32.06
Dividend Yield0.0
Price/Tangible Book Ratio - LTM0.00
Price/Book Ratio - LTM6.98
Price/Cash Flow Ratio31.3
Price/Free Cash Flow Ratio - LTM37.3
Price/Sales Ratio0.00
P/E Ratio (1 month ago) - LTM174.1
P/E Ratio (26 weeks ago) - LTM96.8
P/E Ratio (52 weeks ago) - LTM114.8
5-Y High P/E Ratio81.6
5-Y Low P/E Ratio17.7
5-Y Average P/E Ratio0.0
Current P/E Ratio as % of 5-Y Average P/E-4
P/E as % of Industry Group818.0
P/E as % of Sector Segment654.0
Current 12 Month Normalized P/E Ratio - LTM177.0
PER SHARE FIGURES
LT Debt pS0.00
Current Liabilities pS2.92
Tangible Book Value pS - LTM7.29
Book Value pS - LTM7.77
Capital Invested pS7.29
Cash pS - LTM1.32
Cash Flow pS - LTM1.73
Free Cash Flow pS - LTM1.45
Earnings pS (EPS)0.72
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin16.87
Free Cash Flow Margin 5YEAR AVG0.95
Net Profit Margin0.1
Net Profit Margin - 5YEAR AVRG.0.0
Equity Productivity1.46
Return on Equity (ROE)0.1
Return on Equity (ROE) - 5YEAR AVRG.-0.1
Capital Invested Productivity1.46
Return on Capital Invested (ROCI)-0.1
Return on Capital Invested (ROCI) - 5YEAR AVRG.-0.1
Assets Productivity1.40
Return on Assets (ROA)0.1
Return on Assets (ROA) - 5YEAR AVRG.-0.1
Gross Profit Margin83.7
Gross Profit Margin - 5YEAR AVRG.0.8
EBITDA Margin - LTM9.3
EBIT Margin - LTM6.1
Pre-Tax Profit Margin0.0
Pre-Tax Profit Margin - 5YEAR AVRG.0.0
Effective Tax Rate2.6
Effective Tax Rate - 5YEAR AVRG.-4.1
EFFICIENCY RATIOS
Cash Conversion Cycle
Revenue per Employee475,405
Net Income per Employee30,973
Average Collection Period
Receivables Turnover9.5
Day's Inventory Turnover Ratio
Inventory Turnover0.0
Inventory/Sales0.0
Accounts Payble/Sales2.25
Assets/Revenue0.71
Net Working Capital Turnover1.83
Fixed Assets Turnover6.62
Total Assets Turnover1.4
Revenue per $ Cash8.04
Revenue per $ Plant9.97
Revenue per $ Common Equity1.46
Revenue per $ Capital Invested1.46
Selling, General & Adm/tive (SG&A) as % of Revenue61.3
SG&A Expense as % of Revenue - 5YEAR AVRG.0.9
Research & Devlopment (R&D) as % of Revenue16.3
R&D Expense as % of Revenue - 5YEAR AVRG.16.3

  


Your Recent History
NASDAQ
GHDX
Genomic He..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.